Eubel Brady & Suttman Asset Management’s Elevance Health ELV Stock Holding History

Eubel Brady & Suttman Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-138	Closed	-$50K	–	152
2021 Q2	$50K	Buy	+138	New	+$52.7K	﹤0.01%	334
2016 Q1	–	Sell	-2,050	Closed	-$286K	–	76
2015 Q4	$286K	Hold	2,050	–	–	0.1%	66
2015 Q3	$287K	Sell	2,050 -55	-3%	-$8.27K	0.1%	62
2015 Q2	$346K	Sell	2,105 -102,489	-98%	-$16.4M	0.11%	58
2015 Q1	$16.1M	Sell	104,594 -3,354	-3%	-$478K	4.94%	3
2014 Q4	$13.6M	Sell	107,948 -5,557	-5%	-$687K	4.17%	5
2014 Q3	$13.6M	Sell	113,505 -1,104	-1%	-$127K	4.05%	5
2014 Q2	$12.3M	Sell	114,609 -844	-0.7%	-$87K	3.54%	7
2014 Q1	$11.5M	Sell	115,453 -1,870	-2%	-$169K	3.25%	9
2013 Q4	$10.8M	Sell	117,323 -4,294	-4%	-$382K	3.12%	12
2013 Q3	$10.2M	Sell	121,617 -3,510	-3%	-$301K	2.77%	13
2013 Q2	$10.2M	Buy	+125,127	New	+$9.36M	2.81%	13

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Eubel Brady & Suttman Asset Management's ELV Position: Q3 2021 in Review

Eubel Brady & Suttman Asset Management sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 138 shares — an estimated $50K sold.

Eubel Brady & Suttman Asset Management first reported a position in ELV in Q2 2013 and held it in 12 quarters. The position peaked at $16.1M in Q1 2015. 1,215 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

Eubel Brady & Suttman Asset Management reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
Eubel Brady & Suttman Asset Management sold 138 Elevance Health shares in Q3 2021, an estimated $50K.
Eubel Brady & Suttman Asset Management first reported a position in Elevance Health in Q2 2013 and held it in 12 quarters.
Eubel Brady & Suttman Asset Management's Elevance Health position peaked at $16.1M in Q1 2015.
1,215 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q3 2021, filed 5 Nov 2021.